The H2-K alleles, specifically H2-Kk, H2-Kp, H2-Kq, H2-Kr, and H2-Ks, are critical components of the major histocompatibility complex (MHC) class I in mice. These proteins play a pivotal role in the adaptive immune system by presenting endogenous antigens to cytotoxic T cells. The proper function and expression of MHC class I molecules, including the H2-K alleles, are essential for the immune surveillance against abnormal cells and for the regulation of immune responses. The expression of these proteins is tightly regulated and can be influenced by certain intracellular and extracellular conditions. Various chemical compounds can induce the upregulation of H2-Kk,p,q,r,s expression, engaging different signaling pathways and molecular mechanisms to enhance the immune system's capability to present antigens.
The induction of MHC class I molecules, such as H2-Kk,p,q,r,s, can be initiated by specific chemical compounds that serve as activators. These activators include molecules like Interleukin-2, which directly augments the expression of MHC class I by stimulating immune cells. Compounds like polyinosinic-polycytidylic acid, a synthetic analogue of double-stranded RNA, trigger type I interferon production through toll-like receptor 3, leading to the upregulation of MHC class I expression. Furthermore, molecules such as 5-Azacytidine and sodium butyrate, which modulate epigenetic marks, can lead to increased expression of these molecules by altering the chromatin structure around the MHC class I genes. Additionally, compounds like resveratrol activate longevity genes that have been associated with the upregulation of MHC class I expression. These activators harness a variety of biological pathways, demonstrating the complexity and versatility of the mechanisms governing the expression of MHC class I molecules. Understanding these pathways provides insights into the fundamental aspects of immunological functions and the regulation of antigen presentation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
As a potent endotoxin, lipopolysaccharide triggers a strong upregulation of MHC class I molecules through TLR4-mediated activation of NF-κB. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine induces the expression of MHC class I by inhibiting DNA methyltransferases, leading to hypomethylation and gene activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate increases MHC class I expression levels by inhibiting histone deacetylation, thereby relaxing chromatin structure at the gene loci. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid prompts an increase in MHC class I expression, possibly through the activation of cellular stress response pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has been shown to upregulate MHC class I expression through the activation of SIRT1 and related longevity genes. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod acts as an immune response modifier by inducing the secretion of cytokines that can upregulate MHC class I expression. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol has been shown to increase the expression of MHC class I through its role as a regulator of immune cell differentiation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid stimulates the transcription of genes encoding MHC class I molecules, enhancing antigen presentation capabilities. | ||||||